Following the COVID-19 pandemic, the vision and architecture of Global Health have dramatically evolved, particularly in relation to the EU 2010 Global Health Communication. Against this backdrop, the European Commission launched a public consultation to feed into...
ROBUST – Crisis Governance in Turbulent Times ROBUST aims to set in motion a paradigm shift from ‘resilience’ (‘bouncing back’) to ‘robustness’ (‘building back better’) as the central principle of future crisis governance. The project breaks new ground by...
EPHA analysis of President von der Leyen’s 2022 State of the European Union On 14 September, European Commission President Ursula von der Leyen gave her annual State of the European Union speech (SOTEU). A flagship address, she reflected on the year that has passed...
EPHA has signed the joint statement of the EU4Health Civil Society Alliance calling for the European Commission to include Operating Grants for health NGOs in the EU4Health 2023 Work Programme. Operating Grants are the sole financial mechanism allowing health NGOs,...
Guest article by Robin Doeswijk and Gauthier Quinonez, European Hematology Association Plasma Shortages Plasma-derived medicinal products (PDMPs) are used to treat various rare, chronic, and potentially life-threatening conditions including immune deficiencies,...
